Primary Record
Rivaroxaban
- In stock
- 4,469 g
- Purity
- 99.4 %
- CAS
- 366789-02-8
Compound Identifiers & Properties
- CAS
- 366789-02-8
- PubChem CID
- 9875401
- SMILES
- C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl
- Canonical SMILES
- O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1
Names & Synonyms
- Rivaroxaban
- Xarelto
- 366789-02-8
- rivaroxabanum
- Rivaroxaben
- Rivaroxaban CRS
- Xarelto (TN)
- Rivaroxaban [INN]
- (S)-Rivaroxaban
- BAY 59-7939
- Rivaroxaban/Xarelto/
- Rivaroxaban (Xarelto)
- 9NDF7JZ4M3
- RefChem:6203
- Rivaroxaban (Standard)
- C19H18ClN3O5S
- UNII-9NDF7JZ4M3
- BAY59-7939
- RIVAROXABAN [MI]
- RIVAROXABAN [JAN]
- Rivaroxaban [USAN:INN]
- RIVAROXABAN [USAN]
- D0KG3R
- RIVAROXABAN [VANDF]
- SCHEMBL3914
- Janssen brand of rivaroxaban
- RIVAROXABAN [MART.]
- MFCD11974010
- BAY-59-7939
- DTXSID3057723
- Rivaroxaban (1604530)
- RIVAROXABAN [USP-RS]
- RIVAROXABAN [WHO-DD]
- CHEBI:68579
- HSDB 8149
- MLS006010027
- Rivaroxaban (JAN/USAN/INN)
- RIVAROXABAN [EMA EPAR]
- BDBM7840
- CHEMBL198362
- GTPL6388
- orb1309486
- THI055
- Rivaroxaban - Bio-X trade mark
- Rivaroxaban [USAN:INN:BAN:JAN]
- AMY1799
- B01AF01
- BAY 59-7939 (Rivaroxaban)
- EX-A206
- JNJ39039039
- QCR-276
- RIVAROXABAN [ORANGE BOOK]
- 2w26
- KGFYHTZWPPHNLQ-AWEZNQCLSA-N
- DTXCID601508635
- GLXC-90151
- JNJ-39039039
- RIVAROXABAN [EP MONOGRAPH]
- Rivaroxaban CRS (Y0002187)
- Rivaroxaban Enantiomer (R-Isomer)
- BAY 597939
- AMX10143
- AOB87363
- ZINC3964126
- BAY 59 7939
- Rivaroxaban,Xarelto,BAY 59-7939
- ABP000227
- AN-420
- EBC-07653
- HY-50903R
- MSK158364
- NP3315
- (S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide
- AKOS005145918
- ACN-028789
- CCG-212899
- CID9875401
- CS-0555
- DB06228
- FR27742
- CID:9875401
- NCGC00262945-10
- NCGC00379033-04
- AJ-47544
- BR-72888
- BR164355
- EN002023
- HY-50903
- SMR002529611
- SID:283537523
- AB0009978
- A4338
- 5-Chloro-N-({(5s)-2-Oxo-3-[4-(3-Oxomorpholin-4-Yl)phenyl]-1,3-Oxazolidin-5-Yl}methyl)thiophene-2-Carboxamide
- J2.395.184C
- A10800
- A14979
- D07086
- J10374
- S-4924
- 5-chloro-N-{[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl}thiophene-2-carboxamide
- AB01563270_01
- EN300-6733490
- US8822458, 44
- US8822458, 97
- 789R028
- A848255
- C503223
- Q420262
- SR-01000944189
- 5-CHLORO-N-[[(S)-3-(4-(3-OXOMORPHOLIN-4-YL)PHENYL)-2-OXO-1,3-OXAZOLIDIN-5-YL]METHYL]-THIOPHENE-2-CARBOXAMIDE
- SR-01000944189-1
- BRD-K37130656-001-01-2
- BRD-K37130656-001-03-8
- D000069552
- Z1741977097
- Rivaroxaban Working Standard (Secondary Reference Standard)
- 2-Thiophenecarboxamide, 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-
- 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
- 5-CHLORO-N-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]-2-THIOPHENECARBOXAMIDE
- 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide
- 2-Thiophenecarboxamide, 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)phenyl)-5-oxazolidinyl)methyl)-
- 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl]thiophene-2-carboxamide
- 865479-71-6
- (S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl )thiophene-2-carboxamide
- (S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
- (s)-5-chloro-n-{[2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl} thiophene-2-carboxam
- (S)-5-chloro-N-{[2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl} thiophene-2-carboxamide
- 1429742-50-6
- 2-Thiophenecarboxamide, 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-; 5-Chloro-N-([(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl]-methyl)-2-thiophenecarboxamide; 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl]methyl]-2-thiophenecarboxamide; 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide; 5-Chloro-N-[[(S)-3-(4-(3-oxomorpholin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]-thiophene-2-carboxamide; BAY 59-7939; Rivaroxaban; Xarelto
- 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
- 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
- 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
- 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophencarboxamide
- 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide
- 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
- 5-chloro-N-({(5s)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl} methyl)thiophene-2-carboxamide
- 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidine-5-yl]methyl]thiophene-2-carboxamide
- 5-Chloro-N-{[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl}thiophene-2-carboxamide
- N-[[(5S)-2-Oxo-3-[4-(3-oxomorpholino)phenyl]-5-oxazolidinyl]methyl]-5-chloro-2-thiophenecarboxamide
- N-[[(5S)-3-[4-(3-Oxomorpholine-4-yl)phenyl]-2-oxooxazolidine-5-yl]methyl]-5-chlorothiophene-2-carboxamide
- R-Rivaroxaban; ent-Rivaroxaban; [({(5R)-2-Oxo-3-[p-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)amino](5-chloro-2-thienyl)formaldehyde; 5-Chloro-N-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide
- RIV
- Rivaroxaban; (S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide